Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS Fields Many Suggestions And Criticisms On Proposed VAD Policy

This article was originally published in The Gray Sheet

Executive Summary

Several stakeholders are still pushing CMS to recognize “bridge-to-decision” heart failure patients who may eventually be suitable for a heart transplant but are not so at the time they receive a ventricular assist device.


Related Content

Tug Of War In The LVAD Market
CMS Sticks To Its Original Thinking In Final VAD Coverage Decision
Physicians Want CMS To Rethink Indications For LVADs, Recognize “Bridge-To-Decision” Patients
Medicare Panel Laments Holes In Ventricular Assist Device Evidence Base


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts